We are live on
!
Find out more
Edwards Lifesciences
1,312 hedge funds and large institutions have $43B invested in Edwards Lifesciences in 2025 Q4 according to their latest regulatory filings, with 183 funds opening new positions, 422 increasing their positions, 477 reducing their positions, and 100 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
12% less repeat investments, than reductions
Existing positions increased: 422 | Existing positions reduced: 477
17% less call options, than puts
Call options by funds: $336M | Put options by funds: $407M
20% less funds holding in top 10
Funds holding in top 10: 10 → 8 (-2)
Holders
1,312
Holding in Top 10
8
Calls
$336M
Puts
$407M
Top Buyers
| 1 | +$353M | |
| 2 | +$194M | |
| 3 | +$164M | |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
+$121M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$104M |
Top Sellers
| 1 | -$239M | |
| 2 | -$205M | |
| 3 | -$167M | |
| 4 |
BlackRock
New York
|
-$150M |
| 5 |
Bank of New York Mellon
New York
|
-$125M |